Please use this identifier to cite or link to this item:
Title: Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study
Author: Sanmartí Sala, Raimon
Inciarte-Mundo, Jose
Estrada-Alarcon, Paula
Garcia-Manrique, Maria
Narváez García, Francisco Javier
Rodríguez Moreno, Jesús
Gomez-Centeno, Antoni
Pascal, Mariona
Yagüe, Jordi
Keywords: Artritis reumatoide
Administració de medicaments
Sistema immunològic
Anticossos monoclonals
Rheumatoid arthritis
Administration of drugs
Immune system
Monoclonal antibodies
Issue Date: Aug-2015
Publisher: BMJ Publishing Group
Abstract: We read with great interest the paper by Chen et al1 analysing the relationship between therapeutic response to adalimumab and etanercept and serum drug trough levels in 70 patients with rheumatoid arthritis (RA). ...
Note: Article en format correspondència
Note: Reproducció del document publicat a:
It is part of: Annals of the Rheumatic Diseases, 2015, vol. 74, num. 8, p. e42
Related resource:
ISSN: 0003-4967
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
657895.pdf411.63 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.